Active	Status	Sponsor type	Region	Phase	Filter
4 Active 6 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
senicapoc (ICA-17043) / SpringWorks Therap, UC Davis Health
SpringWorks Therap_C: Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19	Not yet recruiting	2	0	Denmark	senicapoc (ICA-17043) - SpringWorks Therap, UC Davis Health	SpringWorks Therap, UC Davis Health	Novel Coronavirus Disease
Senicapoc, NCT04804241: in Alzheimer's Disease	Recruiting	2	55	US	Senicapoc, TRAM-34, Placebo Tablet	University of California, Davis	Mild Cognitive Impairment, Alzheimer Disease	12/25	06/26
FIBROPOC, NCT06714123: Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease	Not yet recruiting	2	140	Europe	Senicapoc, Placebo	Vejle Hospital, Odense Patient Data Explorative Network	Pulmonary Fibrosis, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis	12/28	12/28
NCT04372498: Senicapoc and Dehydrated Stomatocytosis	Completed	1/2	5	US	Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide)	Boston Children's Hospital	Dehydrated Hereditary Stomatocytosis	02/24	02/24
SAN903 / Saniona
No trials found
Idiopathic pulmonary fibrosis therapeutic / AbCellera
No trials found
BBT-301 / CellionBioMed, Bridge Biotherap
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
senicapoc (ICA-17043) / SpringWorks Therap, UC Davis Health
SpringWorks Therap_C: Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19	Not yet recruiting	2	0	Denmark	senicapoc (ICA-17043) - SpringWorks Therap, UC Davis Health	SpringWorks Therap, UC Davis Health	Novel Coronavirus Disease
Senicapoc, NCT04804241: in Alzheimer's Disease	Recruiting	2	55	US	Senicapoc, TRAM-34, Placebo Tablet	University of California, Davis	Mild Cognitive Impairment, Alzheimer Disease	12/25	06/26
FIBROPOC, NCT06714123: Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease	Not yet recruiting	2	140	Europe	Senicapoc, Placebo	Vejle Hospital, Odense Patient Data Explorative Network	Pulmonary Fibrosis, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis	12/28	12/28
NCT04372498: Senicapoc and Dehydrated Stomatocytosis	Completed	1/2	5	US	Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide)	Boston Children's Hospital	Dehydrated Hereditary Stomatocytosis	02/24	02/24
SAN903 / Saniona
No trials found
Idiopathic pulmonary fibrosis therapeutic / AbCellera
No trials found
BBT-301 / CellionBioMed, Bridge Biotherap
No trials found